The European Journal of Health Economics

Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Latest citations and documents published in this series in EconPapers.

Raw data:
IF AIF DOC CIT D2Y C2Y SC(%) CiY II AII 1996 0.17 0 0 0 0.08 1997 0.2 0 0 0 0.08 1998 0.23 0 0 0 0.1 1999 0.32 0 0 0 0.16 2000 0.43 0 0 0 0.19 2001 0.39 0 0 0 0.17 2002 0.42 0 0 0 0.2 2003 0.47 0 0 0 0.22
IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CIT: Number of citations to the series in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 SC(%): Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y IdI: Immediacy Index: CiY / Documents.   AII: Average Immediacy Index for series in RePEc in year y
Impact Factor:
Immediacy Index:
Documents published:
Citations received:

Most cited documents in this series:

(1) RePEc:spr:eujhec:v:7:y:2006:i:1:p:7-18 The relationship between health care expenditure and health outcomes (2006). The European Journal of Health Economics
Cited: 4 times.

(2) RePEc:spr:eujhec:v:7:y:2006:i:1:p:37-45 Fixed budgets as a cost containment measure for pharmaceuticals (2006). The European Journal of Health Economics
Cited: 2 times.

(3) RePEc:spr:eujhec:v:7:y:2006:i:3:p:204-211 Price regulation and generic competition in the pharmaceutical market (2006). The European Journal of Health Economics
Cited: 2 times.

(4) RePEc:spr:eujhec:v:8:y:2007:i:3:p:253-266 Patient access to pharmaceuticals: an international comparison (2007). The European Journal of Health Economics
Cited: 1 times.

(5) RePEc:spr:eujhec:v:7:y:2006:i:4:p:223-224 Time for a common standard for cost-effectiveness in Europe? (2006). The European Journal of Health Economics
Cited: 1 times.

(6) RePEc:spr:eujhec:v:7:y:2006:i:3:p:165-172 A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany (2006). The European Journal of Health Economics
Cited: 1 times.

(7) RePEc:spr:eujhec:v:8:y:2007:i:1:p:1-3 Should we really worry about “launch delays” of new drugs in OECD countries? (2007). The European Journal of Health Economics
Cited: 1 times.

(8) RePEc:spr:eujhec:v:7:y:2006:i:1:p:79-83 Off-patent drugs in Italy (2006). The European Journal of Health Economics
Cited: 1 times.

Latest citations received in: | 2003 | 2002 | 2001 | 2000

Latest citations received in: 2003

Latest citations received in: 2002

Latest citations received in: 2001

Latest citations received in: 2000

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.